SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 1352.33 millions for the March 2024 quarter. The mentioned figure indicates a growth of about 27.72% as compared to Rs. 1058.79 millions during the year-ago period.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 375.39  millions as against Rs. 530.96 millions reported during the corresponding quarter ended.Operating profit for the quarter ended March 2024 rose to 610.75 millions as compared to 142.33 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1352.33 1058.79 27.72 5022.48 4109.58 22.21 5022.48 4109.58 22.21
Other Income 465.90 62.79 642.00 579.93 118.54 389.23 579.93 118.54 389.23
PBIDT 610.75 142.33 329.11 1065.08 538.87 97.65 1065.08 538.87 97.65
Interest 144.29 144.78 -0.34 629.36 597.62 5.31 629.36 597.62 5.31
PBDT 466.46 603.34 -22.69 435.72 547.04 -20.35 435.72 547.04 -20.35
Depreciation 68.75 72.38 -5.02 271.07 286.68 -5.45 271.07 286.68 -5.45
PBT 397.71 530.96 -25.10 164.65 260.36 -36.76 164.65 260.36 -36.76
TAX 22.32 0.00 0.00 22.32 0.00 0.00 22.32 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 375.39 530.96 -29.30 142.33 260.36 -45.33 142.33 260.36 -45.33
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 45.16 13.44 235.97 21.21 13.11 61.73 21.21 13.11 61.73

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×